Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Sloan Kettering Institute
Research
- - Changing how the world understands and treats cancer
    Our scientists pursue every aspect of cancer research—from exploring the biology of genes and cells, to developing immune-based treatments, uncovering the causes of metastasis, and more.
- - Programs & Centers
  - Sloan Kettering Institute
    Pursuing basic and translational research across 9 programs and 100+ labs
  - Memorial Hospital research
    Focusing on clinical cancer research and population health
  - Human Oncology & Pathogenesis Program (HOPP)
    Bridging the lab and the clinic through translational research
  - Collaborative research centers
    Fostering interdisciplinary collaborations between laboratory scientists and clinicians
  - Extramural collaborations
    Partnering with other academic and research institutions
- - Research at MSK
  - Our research impact
  - Research topics
  - Core facilities & resources
    Offering state-of-the-art resources for our researchers
  - Find a researcher or lab
  - Education & training programs
Education & Training
- - Training the next generation of clinicians and scientists
    Our highly-specialized educational programs shape leaders to be at the forefront of cancer care and research.
Careers
MSK Direct
Locations & Language
In the U.S.
Outside of the U.S.

Make an Appointment
Back
Make an Appointment
- - We’re here for you.
    Make an appointment
    New patient
    Current patient
    Speak to a care advisor
    Adults: 800-525-2225
    Available 24 hours a day, 7 days a week
    Children & Teens: 833-MSK-KIDS
    Monday through Friday, 9 a.m. to 5:30 p.m. (Eastern time)
- - Becoming A Patient
  - How to get started
  - Insurance & financial assistance
  - Preparing for your first appointment
  - Meet our doctors
  - Explore our locations
Learn About Cancer & Treatment
Back
Learn About Cancer & Treatment
- - We treat every type of cancer, including the most important one: yours.
    With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need, when you need it.
- - Adults
  - Cancers & conditions
  - Risk assessment & screening
  - Diagnosis & treatment
  - Clinical trials
  - Children & Teens
  - Cancers & conditions
  - Diagnosis & treatment
  - Clinical trials
- - Support, Services & Programs
  - For adults
  - For children & teens
  - For caregivers
  - Adolescents & young adult (AYA) program
  - Patient & caregiver education library
  - Cancer News & Discoveries
  - Read the latest
  - Sign up for our newsletter
For Physicians
Back
For Physicians
- - Partner with us to treat your patient’s cancer.
    Refer a patient
    CALL OUR DEDICATED CLINICIAN ACCESS NUMBER
    646-677-7440
    Monday through Friday, 8 a.m. to 6 p.m. (Eastern time)
- - Clinical Resources
  - Our doctors
  - Physician relations
  - Clinical updates & insights
  - Prediction tools
  - Clinical trials
  - Continuing medical education (CME)
About Us
Back
About Us
- - Our mission: Ending cancer for life.
    Memorial Sloan Kettering was founded in 1884, and today is a world leader in patient care, research, and educational programs.
- - About Us
  - Our mission, vision & core values
  - Leadership
  - History
  - Equality, diversity & inclusion
  - Annual report
  - Give to MSK
  - For the Media
  - Media inquiries
  - Press Releases
  - Newsroom
- - Have Questions?
  - Contact us
  - Plan Your Visit
  - Explore our locations
  - Directions
  - Visitor policy
Patient Portal: MyMSK
Donate Now
- Sloan Kettering Institute
- Research
  Back
  Research
  - Programs & Centers
    Sloan Kettering Institute
    Pursuing basic and translational research across 9 programs and 100+ labs
    Memorial Hospital research
    Focusing on clinical cancer research and population health
    Human Oncology & Pathogenesis Program (HOPP)
    Bridging the lab and the clinic through translational research
    Collaborative research centers
    Fostering interdisciplinary collaborations between laboratory scientists and clinicians
    Extramural collaborations
    Partnering with other academic and research institutions
  - Research at MSK
    Our research impact
    Research topics
    Core facilities & resources
    Offering state-of-the-art resources for our researchers
    Find a researcher or lab
    Education & training programs
- Education & Training
  Back
  Education & Training
  - For Healthcare
    Graduate medical education (GME)
    Medical student opportunities
    Continuing medical education (CME)
    Continuing nursing education (CNE)
    Academic departments & divisions
    Explore all programs
  - For Research
    Postdoctoral training
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences
    PhD & MD/PhD programs
    Explore all programs
- Careers
- MSK Direct
- Locations & Language
  Back
  Locations & Language
  In the U.S.
  English
  Español
  Pусский
  Outside of the U.S.
  العَرَبِيَّة
  Deutsch
  English
  Español
  한국어
  עִבְרִית
  Italiano
  Portugês
  Pу́сский
  Türkçe
  中文

Radiochemistry & Molecular Imaging Probes

Share

Overview

Serge K. Lyashchenko

Director

At Memorial Sloan Kettering, researchers have translated numerous new radiopharmaceuticals into the clinic for both imaging and therapy purposes. The Radiochemistry and Molecular Imaging Probe (RMIP) Core Facility serves these investigators by supplying a variety of radiopharmaceuticals , including radiolabeled small molecules, peptides, antibodies, and nanoparticles that can be imaged by methods such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT). It also supplies nonradioactive molecular imaging probes for use with non-nuclear detection systems. Our services support both basic research investigations and patient imaging.

Serge Lyashchenko in the cyclotron facility — Radiopharmacist Serge Lyashchenko preparing a reagent in the cyclotron facility.

RMIP Core group — Radiochemistry and Molecular Imaging Probe Core

Featured News

In the Clinic

Pictured: Serge Lyashchenko

How Our New Particle Accelerator Will Make Cancer Imaging and Treatment More Precise

Friday, June 27, 2014

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.

Novel Cancer-Targeting Investigational Nanoparticle Receives FDA IND Approval for First-In-Human Trial

Monday, January 31, 2011

Researchers at Memorial Sloan Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.

People

Serge K. Lyashchenko
Director

Members

Jason S. Lewis — Jason S. Lewis
Scientific Director

Shake Ahmmed — Shake Ahmmed
RMIP Core Radiopharmacist

Stephanie Cheung — Stephanie Cheung
RMIP Core Radiopharmacist

Sam Frackowiak — Sam Frackowiak
Manager, RMIP Core Manufacturing

Hijin A. Park — Hijin A. Park
Lead, Nuclear Pharmacist

Andrew Rivera
Radiopharmacy Tech I

Giovanni Saint-Victor — Giovanni Saint-Victor
RMIP Core Systems Specialist

Tricia Taylor — Tricia Taylor
RMIP Core Project Manager

Tuan Tran — Tuan Tran
Manager, RMIP Core Manufacturing

Angelo Valdivia — Angelo Valdivia
Sr. Radiopharmacy Technician

Jiong "Lilly" Wu — Jiong "Lilly" Wu
Research Technician, Sr.

Alumni

Ariel Brown — Ariel Brown
Radiopharmacy QA Specialist

Phillip DeNoble — Phillip DeNoble
RMIP Core Radiopharmacist

Yorann Roux — Yorann Roux
Clinical Radiochemist

Yiauchung "Howard" Sheh — Yiauchung "Howard" Sheh
Senior Cyclotron Engineer

Kevin Staton — Kevin Staton
Project Manager, Funds

Eva Burnazi — Eva Burnazi
Clinical Radiochemist

Steve Carlin — Steve Carlin
Clinical Radiochemist

Sherron Hicks — Sherron Hicks
Cyclotron Engineer

Calvin Lom — Calvin Lom
Cyclotron Engineer

Aisha Shickler — Aisha Shickler
Senior Research Technician

Tristan Tiongson
RMIP Core Radiopharmacist

Scott Vietri — Scott Vietri
Lead, Nuclear Pharmacist

Christopher Yung — Christopher Yung
RMIP Core Radiopharmacist

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

Get in Touch

[email protected]

Director Email